Product Specification
| PRODUCT | STATUS |
|---|---|
| Fen-Touch | On market in India |
| Artho-Touch | On market in India |
| Diclo-Touch | On market in India |
| Tulobuterol Patch | In process of regulatory review |
Product Description
Transdermal drug delivery is defined as not involving the introduction of instruments into the body it delivery the medications through the skin surface. The use of Fentanyl as a 'Pain drug patch' is gaining popularity. When applied to the skin, these patches can deliver a Fentanyl drug at a predetermined rate across the dermis to realize either an area or systemic effect.
Sparsha Pharma International Pvt. Ltd. was established in 2008 as the first transdermal company in India to engage in R&D, Manufacturing of Pain drug patch products for global markets.
Advantages
- Pain drug patches offer advantages over conventional skin routes.
- They ensure controlled absorption and more uniform pain drug concentrations.
- The delivery of the drug is via a simple and painless application.
- here is increased flexibility in terminating drug administration by Pain drug patch adjustment.
- Patient compliance is improved as patches are simple, not involving the introduction of instruments into the body, and convenient.
- Clear labeling ensures rapid identification of medication.
